TY - JOUR
T1 - Evaluation of the liver for metastatic disease
AU - Paulson, E. K.
N1 - Copyright:
Copyright 2007 Elsevier B.V., All rights reserved.
PY - 2001
Y1 - 2001
N2 - Metastatic disease of the liver accounts for the vast majority of detected liver masses. In patients with suspected metastatic disease, cross-sectional imaging with ultrasound (US), computed tomography (CT), or magnetic resonance imaging (MRI) is critical. In the group of patients undergoing evaluation for hepatic surgery, it is even more important to optimize techniques to detect and localize metastatic disease. With improvements in technology and contrast agents, there are several approaches to imaging the liver for metastatic disease. The approach will vary by institution. This article will attempt to provide an overview of the general issues relevant to imaging metastatic disease, highlight the advantages and disadvantages of one modality compared to another, and illustrate the appearance of metastases using US, CT, and MRI.
AB - Metastatic disease of the liver accounts for the vast majority of detected liver masses. In patients with suspected metastatic disease, cross-sectional imaging with ultrasound (US), computed tomography (CT), or magnetic resonance imaging (MRI) is critical. In the group of patients undergoing evaluation for hepatic surgery, it is even more important to optimize techniques to detect and localize metastatic disease. With improvements in technology and contrast agents, there are several approaches to imaging the liver for metastatic disease. The approach will vary by institution. This article will attempt to provide an overview of the general issues relevant to imaging metastatic disease, highlight the advantages and disadvantages of one modality compared to another, and illustrate the appearance of metastases using US, CT, and MRI.
KW - Computed tomography
KW - Liver
KW - Magnetic resonance imaging
KW - Metastases detection
KW - Metastasis of the liver
UR - http://www.scopus.com/inward/record.url?scp=0034971952&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034971952&partnerID=8YFLogxK
U2 - 10.1055/s-2001-15498
DO - 10.1055/s-2001-15498
M3 - Article
C2 - 11436574
AN - SCOPUS:0034971952
SN - 0272-8087
VL - 21
SP - 225
EP - 236
JO - Seminars in Liver Disease
JF - Seminars in Liver Disease
IS - 2
ER -